Both in Pharmaceuticals
United Therapeutics vs BridgeBio Pharma
Over the past year UTHR returned +34.4% and BBIO returned +19.7%; their daily moves had a correlation of 0.12.
UTHR +34.4% BBIO +19.7%Growth of $1, one year, split-adjusted
| Metric | UTHR | BBIO |
|---|---|---|
| Price | $598.72 | $74.95 |
| Market cap | $25.68B | $14.60B |
| Today | +0.87% | +5.97% |
| 1 month | +4.8% | +12.0% |
| 6 months | +5.0% | +9.3% |
| Year to date | +22.9% | −2.0% |
| 1 year | +31.5% | +12.5% |
| Revenue growth (YoY) | −1.9% | +192.6% |
| Gross margin | 87.3% | 94.2% |
| Net margin | 42.5% | −23.5% |
| P/E (TTM) | 19.6× | — |
| Price / sales | 8.1× | 15.4× |
| Net cash | $2.66B | -$938.6M |
| Dividend yield | — | — |
| Volatility (60d) | 37.7% | 32.7% |
| Short % of float | 5.9% | 12.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).